197 related articles for article (PubMed ID: 26851261)
1. Regulation of myofibroblast differentiation by cardiac glycosides.
La J; Reed EB; Koltsova S; Akimova O; Hamanaka RB; Mutlu GM; Orlov SN; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L815-23. PubMed ID: 26851261
[TBL] [Abstract][Full Text] [Related]
2. Na+,K+-ATPase as a Target for Treatment of Tissue Fibrosis.
Orlov SN; La J; Smolyaninova LV; Dulin NO
Curr Med Chem; 2019; 26(3):564-575. PubMed ID: 28625151
[TBL] [Abstract][Full Text] [Related]
3. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
Kach J; Sandbo N; Sethakorn N; Williams J; Reed EB; La J; Tian X; Brain SD; Rajendran K; Krishnan R; Sperling AI; Birukov K; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L757-64. PubMed ID: 23585227
[TBL] [Abstract][Full Text] [Related]
4. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
5. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
Gentile DA; Henry J; Katz AJ; Skoner DP
Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
[TBL] [Abstract][Full Text] [Related]
7. Control of lung myofibroblast transformation by monovalent ion transporters.
Dulin NO; Smolyaninova LV; Orlov SN
Curr Top Membr; 2019; 83():15-43. PubMed ID: 31196603
[TBL] [Abstract][Full Text] [Related]
8. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta.
Sandbo N; Kregel S; Taurin S; Bhorade S; Dulin NO
Am J Respir Cell Mol Biol; 2009 Sep; 41(3):332-8. PubMed ID: 19151320
[TBL] [Abstract][Full Text] [Related]
9. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Na
Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
13. The Novel mTOR Complex 1/2 Inhibitor P529 Inhibits Human Lung Myofibroblast Differentiation.
Ferguson KT; Torr EE; Bernau K; Leet J; Sherris D; Sandbo N
J Cell Biochem; 2017 Aug; 118(8):2241-2249. PubMed ID: 28078713
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
Kottmann RM; Trawick E; Judge JL; Wahl LA; Epa AP; Owens KM; Thatcher TH; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1305-12. PubMed ID: 26408551
[TBL] [Abstract][Full Text] [Related]
15. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
17. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z
Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415
[TBL] [Abstract][Full Text] [Related]
18. Cardiac glycosides regulate endothelial tissue factor expression in culture.
Stähli BE; Breitenstein A; Akhmedov A; Camici GG; Shojaati K; Bogdanov N; Steffel J; Ringli D; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2769-76. PubMed ID: 18029910
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic effects of noscapine through activation of prostaglandin E2 receptors and protein kinase A.
Kach J; Sandbo N; La J; Denner D; Reed EB; Akimova O; Koltsova S; Orlov SN; Dulin NO
J Biol Chem; 2014 Mar; 289(11):7505-13. PubMed ID: 24492608
[TBL] [Abstract][Full Text] [Related]
20. Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na
Fujii T; Katoh M; Ootsubo M; Nguyen OTT; Iguchi M; Shimizu T; Tabuchi Y; Shimizu Y; Takeshima H; Sakai H
J Cell Physiol; 2022 Jul; 237(7):2980-2991. PubMed ID: 35511727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
